Neuropathic Pain.
Study Goal
The researchers aimed to evaluate the role of massage therapy as a nonpharmacologic adjunctive treatment for neuropathic pain management.
Results Summary
The abstract notes that massage therapy is used in clinical practice for neuropathic pain, but the current evidence supporting its efficacy is not strong. No specific outcomes or statistical results are provided.
Population
Patients with neuropathic pain (not further specified).
Effective Dosage
Not available
Duration
Not available
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
tricyclic antidepressants | neutral | neuropathic pain management | - | - | have the strongest supporting evidence | #1 |
serotonin-norepinephrine reuptake inhibitors | neutral | neuropathic pain management | - | - | have the strongest supporting evidence | #2 |
certain antiseizure agents | neutral | neuropathic pain management | - | - | have the strongest supporting evidence | #3 |
cannabinoids | neutral | neuropathic pain management | - | - | emerging evidence for the use | #4 |
acupuncture | neutral | neuropathic pain management | - | - | have been utilized | #5 |
massage therapy | neutral | neuropathic pain management | - | - | have been utilized | #6 |
reflexology | neutral | neuropathic pain management | - | - | have been utilized | #7 |
Neuropathic pain management is challenging, and typically requires a multifaceted approach. There are several treatment options, both pharmacologic and nonpharmacologic. Of the available pharmacologic agents, those with the strongest supporting evidence include tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, and certain antiseizure agents. There is emerging evidence for the use of cannabinoids, but conclusive studies are not available. Nonpharmacologic therapies that have been utilized in the management of neuropathic pain include acupuncture, massage therapy, and reflexology. Despite their use as adjunctive therapies in clinical practice, the current evidence supporting their use is not strong. For the management of neuropathic pain, combination therapies are generally employed. Additional studies for emerging therapies are still needed.